[1] |
Dixon MJ, Marazita ML, Beaty TH, et al. Cleft lip and palate:understanding genetic and environmental influences. Nat Rev Genet, 2011; 12, 167-78. http://www.ncbi.nlm.nih.gov/pubmed/21331089 |
[2] |
Li H, Luo M, Luo J, et al. A discriminant analysis prediction model of non-syndromic cleft lip with or without cleft palate based on risk factors. BMC Pregnancy Childbirth, 2016; 16, 368. doi: 10.1186/s12884-016-1116-4 |
[3] |
Stuppia L, Capogreco M, Marzo G, et al. Genetics of syndromic and nonsyndromic cleft lip and palate. J Craniofac Surg, 2011; 22, 1722-6. doi: 10.1097/SCS.0b013e31822e5e4d |
[4] |
Vieira AR, Orioli IM, Castilla EE, et al. MSX1 and TGFB3 contribute to clefting in South America. J Dent Res, 2003; 82, 289-92. doi: 10.1177/154405910308200409 |
[5] |
Zucchero TM, Cooper ME, Maher BS, et al. Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. N Engl J Med, 2004; 351, 769-80. doi: 10.1056/NEJMoa032909 |
[6] |
Sozen MA, Hecht JT, Spritz RA. Mutation and association analysis of the PVR and PVRL2 genes in patients with non-syndromic cleft lip and palate. Genet Mol Biol, 2009; 32, 466-9. doi: 10.1590/S1415-47572009000300007 |
[7] |
Liu YP, Xu LF, Wang Q, et al. Identification of susceptibility genes in non-syndromic cleft lip with or without cleft palate using whole-exome sequencing. Medicina Oral Patología Oral y Cirugia Bucal, 2015; 20, 763-70. http://europepmc.org/articles/PMC4670259 |
[8] |
Ernst R, Mueller B, Ploegh HL, et al. The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol Cell, 2009; 36, 28-38. doi: 10.1016/j.molcel.2009.09.016 |
[9] |
Juan Zhang, Xiaofei Zhang, Feng Xie, et al. The regulation of TGF-β/SMAD signaling by protein deubiquitination. Protein Cell, 2014; 5, 503-17. doi: 10.1007/s13238-014-0058-8 |
[10] |
Wicks SJ, Haros K, Maillard M, et al. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene, 2005; 24, 8080-4. doi: 10.1038/sj.onc.1208944 |
[11] |
Zhang L, Zhou F, Drabsch Y, et al. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-beta type Ⅰ receptor. Nat Cell Biol, 2012; 14, 717-26. doi: 10.1038/ncb2522 |
[12] |
Herhaus L, Al-Salihi M, Macartney T, et al. OTUB1 enhances TGFbeta signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nat Commun, 2013; 4, 2519. doi: 10.1038/ncomms3519 |
[13] |
Greene RM, Pisano MM. Palate morphogenesis:current understanding and future directions. Birth Defects Res C Embryo Today, 2010; 90, 133-54. doi: 10.1002/(ISSN)1542-9768 |
[14] |
Kohama K, Nonaka K, Hosokawa R, et al. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J Dent Res, 2002; 81, 688-94. doi: 10.1177/154405910208101007 |
[15] |
Reutter H, Birnbaum S, Mende M, et al. TGFB3 displays parent-of-origin effects among central Europeans with nonsyndromic cleft lip and palate. J Hum Genet, 2008; 53, 656-61. doi: 10.1007/s10038-008-0296-9 |
[16] |
Wang HY, Qiu T, Shi J, et al. Gene expression profiling analysis contributes to understanding the association between non-syndromic cleft lip and palate, and cancer. Mol Med Rep, 2016; 13, 2110-6. doi: 10.3892/mmr.2016.4802 |
[17] |
Iyyanar PPR, Nazarali AJ. Hoxa2 Inhibits Bone Morphogenetic Protein Signaling during Osteogenic Differentiation of the Palatal Mesenchyme. Front Physiol, 2017; 8, 929. doi: 10.3389/fphys.2017.00929 |
[18] |
Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003; 113, 685-700. doi: 10.1016/S0092-8674(03)00432-X |
[19] |
Hata A, Chen YG. TGF-beta Signaling from Receptors to Smads. Cold Spring Harb Perspect Biol, 2016; 8. http://uu.diva-portal.org/smash/record.jsf?pid=diva2%3A393861&dswid=-8907 |
[20] |
Jiang R, Bush JO, Lidral AC. Development of the upper lip:morphogenetic and molecular mechanisms. Dev Dyn, 2006; 235, 1152-66. doi: 10.1002/(ISSN)1097-0177 |
[21] |
Wang LQ, Zhang Y, Yan H, et al. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer. Biochem Biophys Res Commun, 2015; 459, 515-20. doi: 10.1016/j.bbrc.2015.02.138 |
[22] |
Powder KE, Ku YC, Brugmann SA, et al. A cross-species analysis of microRNAs in the developing avian face. PLoS One, 2012; 7, e35111. doi: 10.1371/journal.pone.0035111 |
[23] |
Liu Y, Huang T, Zhao X, et al. MicroRNAs modulate the Wnt signaling pathway through targeting its inhibitors. Biochem Biophys Res Commun, 2011; 408, 259-64. doi: 10.1016/j.bbrc.2011.04.009 |
[24] |
Dudas M, Kaartinen V. Tgf-beta superfamily and mouse craniofacial development:interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. Curr Top Dev Biol, 2005; 66, 65-133. doi: 10.1016/S0070-2153(05)66003-6 |
[25] |
Proetzel G, Pawlowski SA, Wiles MV, et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet, 1995; 11, 409-14. doi: 10.1038/ng1295-409 |
[26] |
Ichikawa E, Watanabe A, Nakano Y, et al. PAX9 and TGFB3 are linked to susceptibility to nonsyndromic cleft lip with or without cleft palate in the Japanese:population-based and family-based candidate gene analyses. J Hum Genet, 2006; 51, 38-46. doi: 10.1007/s10038-005-0319-8 |
[27] |
Zhu J, Hao L, Li S, et al. MTHFR, TGFB3, and TGFA polymorphisms and their association with the risk of non-syndromic cleft lip and cleft palate in China. Am J Med Genet A, 2010; 152A, 291-8. doi: 10.1002/ajmg.a.v152a:2 |
[28] |
Gaarenstroom T, Hill CS. TGF-beta signaling to chromatin:how Smads regulate transcription during self-renewal and differentiation. Semin Cell Dev Biol, 2014; 32, 107-18. doi: 10.1016/j.semcdb.2014.01.009 |
[29] |
Dupont S, Inui M, Newfeld SJ. Regulation of TGF-beta signal transduction by mono-and deubiquitylation of Smads. FEBS Lett, 2012; 586, 1913-20. doi: 10.1016/j.febslet.2012.03.037 |
[30] |
Kaartinen V, Voncken JW, Shuler C, et al. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet, 1995; 4, 415-21. http://europepmc.org/abstract/MED/7493022 |